Showing 101 - 120 results of 186 for search '"antipsychotic"', query time: 0.06s Refine Results
  1. 101

    Acute Enterovirus Encephalitis as a Cause for Isolated Visual and Auditory Hallucinations in a 22-Year-Old Patient by M. Deest, C. Eberlein, S. Bleich, H. Frieling, T. Skripuletz, A. Neyazi

    Published 2021-01-01
    “…Under treatment with risperidone and olanzapine, symptoms suddenly stopped and did not reoccur under subsequent reduction of the antipsychotic medication.…”
    Get full text
    Article
  2. 102

    Auditory Hallucinations as a Rare Presentation of Occipital Infarcts by Firas Ido, Reina Badran, Brandon Dmytruk, Zain Kulairi

    Published 2018-01-01
    “…The patient’s symptoms were self-limited, resolving without antipsychotic medications. Psychosis with auditory hallucinations is not commonly reported following stroke. …”
    Get full text
    Article
  3. 103

    Paliperidone Inducing Concomitantly Syndrome of Inappropriate Antidiuretic Hormone, Neuroleptic Malignant Syndrome, and Rhabdomyolysis by Jaspinder Kaur, Dileep Kumar, Mostafa Alfishawy, Ricardo Lopez, Issac Sachmechi

    Published 2016-01-01
    “…Paliperidone, an active metabolite of risperidone, is a new atypical antipsychotic agent. Syndrome of inappropriate antidiuretic hormone (SIADH), neuroleptic malignant syndrome (NMS), and rhabdomyolysis are the uncommon side effects of psychotropic drugs. …”
    Get full text
    Article
  4. 104

    Hashimoto’s Encephalopathy Presenting with Unusual Behavioural Disturbances in an Adolescent Girl by Murugan Selvaraj Karthik, Kulothungan Nandhini, Viswanath Subashini, Ramasamy Balakrishnan

    Published 2017-01-01
    “…Since patient started showing clinical improvement, her antipsychotic medications were tapered off. On follow-up, patient has recovered and is functioning well. …”
    Get full text
    Article
  5. 105

    Decreased Clostridium Abundance after Electroconvulsive Therapy in the Gut Microbiota of a Patient with Schizophrenia by Misako Kanayama, Maiko Hayashida, Sadayuki Hashioka, Tsuyoshi Miyaoka, Masatoshi Inagaki

    Published 2019-01-01
    “…A 59-year-old woman was diagnosed with schizophrenia at 17 years of age and has been taking antipsychotic drugs since the diagnosis. Clostridium, which occupied 86.5% of her bacterial flora, decreased to 72.5% after 14 ECT sessions, while Lactobacillus increased from 1.2% to 5.5%, and Bacteroides increased from 9.1% to 31.5%. …”
    Get full text
    Article
  6. 106

    Fully automated in vivo screening system for multi-organ imaging and pharmaceutical evaluation by Junhan Duan, Guanming Lin, Kangjian Jiao, Xiaohui Hong, Xudong Lin

    Published 2025-01-01
    “…Using this platform, we examine the cardiac sensitivity of an antipsychotic drug with multiple concentration gradients, and reveal dramatic diversity and complexity in the accurate chemical regulation of cardiac functions in vivo. …”
    Get full text
    Article
  7. 107
  8. 108

    Acute Pulmonary Embolism Associated with Low-Dose Olanzapine in a Patient without Risk Factors for Venous Thromboembolism by Vu Hoang Vu, Nguyen Duong Khang, Mai Thanh Thao, Le Minh Khoi

    Published 2021-01-01
    “…Olanzapine is a second-generation antipsychotic drug commonly prescribed for certain mental/mood conditions such as schizophrenia and bipolar disorders. …”
    Get full text
    Article
  9. 109

    Corticolimbic circuitry as a druggable target in schizophrenia spectrum disorders: a narrative review by Abigail Gee, Paola Dazzan, Anthony A. Grace, Gemma Modinos

    Published 2025-01-01
    “…Understanding how neural circuitry and molecular mechanisms within this corticolimbic system may contribute to the development of not only positive symptoms but also negative and cognitive deficits in SSD has been a recent focus of intense research, as the latter are not adequately treated by current antipsychotic medications and are more strongly associated with poorer functioning and long-term outcomes. …”
    Get full text
    Article
  10. 110

    Selective Glucocorticoid Receptor (GR-II) Antagonist Reduces Body Weight Gain in Mice by Tomoko Asagami, Joseph K. Belanoff, Junya Azuma, Christine M. Blasey, Robin D. Clark, Philip S. Tsao

    Published 2011-01-01
    “…Previous research has shown that mifepristone can prevent and reverse weight gain in animals and human subjects taking antipsychotic medications. This proof-of-concept study tested whether a more potent and selective glucocorticoid receptor antagonist could block dietary-induced weight gain and increase insulin sensitivity in mice. …”
    Get full text
    Article
  11. 111

    Assessment of Protective Effects of Carvacrol on Haloperidol-Induced Oxidative Stress and Genotoxicity in Human Peripheral Blood Lymphocytes by Ehsan Zamani, Alireza Ahmadi Shad, Hediye Fatemi, Saba Mahboubi, Azadeh Motavallian, Mehdi Evazalipour

    Published 2022-01-01
    “…Haloperidol is a first-generation antipsychotic drug that has several indications in a wide range of mental conditions. …”
    Get full text
    Article
  12. 112

    Considerations of HLA, Renal Failure, Valproic Acid Use, and Current Treatment Guidelines in Clozapine-Induced Agranulocytosis by Melissa Sussman, Michael Epifania, Derrick Eng, Yun Jae Cho, Richard Steward

    Published 2021-01-01
    “…Clozapine, the choice atypical antipsychotic for refractory schizophrenia, schizoaffective disorder, and bipolar disorder, has been shown to reduce positive and negative symptoms of schizophrenia. …”
    Get full text
    Article
  13. 113

    Clozapine-Induced Cardiotoxicity Presenting as Sepsis: A Case Report and Literature Review by Mazin Khalid, Oluwole Jegede, Vijay Gayam, Ying Chi Yang, Binav Shrestha, Amrendra Mandal, Osama Mukhtar, Pavani Garlapati, Mowyad Khalid, Alix Dufresne

    Published 2019-01-01
    “…Clozapine is an atypical antipsychotic agent indicated in the treatment of medication-resistant schizophrenia. …”
    Get full text
    Article
  14. 114

    The clinical profile and outcome of patients receiving continuation electroconvulsive therapy (C-ECT): A retrospective study by Sandeep Grover, Sanjana Kathiravan, Subho Chakrabarti

    Published 2023-06-01
    “…The most common indication was persistent psychotic symptoms poorly responding to multiple antipsychotic trials of 3.09 (SD: 1.39), including clozapine. …”
    Get full text
    Article
  15. 115

    Clozapine-Induced Late Agranulocytosis and Severe Neutropenia Complicated with Streptococcus pneumonia, Venous Thromboembolism, and Allergic Vasculitis in Treatment-Resistant Femal... by Christina Voulgari, Raphael Giannas, Georgios Paterakis, Anna Kanellou, Nikolaos Anagnostopoulos, Stamata Pagoni

    Published 2015-01-01
    “…Clozapine is a second-generation antipsychotic agent from the benzodiazepine group indicated for treatment-resistant schizophrenia and other psychotic conditions. …”
    Get full text
    Article
  16. 116

    The Effect of Adjuvant Therapy on Metabolic Syndrome in Schizophrenia Patients at Madani Hospital by Indah Kurnia Utami, Yasinta Rakanita, Patricia Novina Nurak, Niluh Puspita Dewi

    Published 2024-11-01
    “…In recent years, atypical antipsychotics have been increasingly prescribed because they significantly reduce both positive and negative symptoms. …”
    Get full text
    Article
  17. 117

    Development and Validation of a GC-MS Method for the Detection and Quantification of Clotiapine in Blood and Urine Specimens and Application to a Postmortem Case by Giulio Mannocchi, Flaminia Pantano, Roberta Tittarelli, Miriam Catanese, Federica Umani Ronchi, Francesco Paolo Busardò

    Published 2015-01-01
    “…Clotiapine is an atypical antipsychotic of the dibenzothiazepine class introduced in a few European countries since 1970, efficient in treatment-resistant schizophrenic patients. …”
    Get full text
    Article
  18. 118

    Effectiveness of positive allosteric modulators of metabotropic glutamate receptor 2/3 (mGluR2/3) in animal models of schizophrenia by David Olivares-Berjaga, Albert Martínez-Pinteño, Natalia Rodríguez, Sergi Mas, Constanza Morén, Eduard Parellada, Patricia Gassó

    Published 2025-01-01
    “…Abstract Schizophrenia (SZ) is a deleterious brain disorder characterised by its heterogeneity and complex symptomatology consisting of positive, negative and cognitive deficits. Current antipsychotic drugs ameliorate the positive symptomatology, but are inefficient in treating the negative symptomatology and cognitive deficits. …”
    Get full text
    Article
  19. 119

    Lack of Clinically Meaningful Effect of Cariprazine on the Pharmacokinetics of a Combined Oral Contraceptive by Márta Erzsébet Rosa, Zoltán Juhász, Gabriella Pásztor Mészáros, Gabriella Magyar, Judit Harsányi, Balázs Szatmári, Zoltán Hujber, Máté Szabó, Margit Kapás

    Published 2024-12-01
    “…Abstract Introduction Cariprazine (CAR) is a potent dopamine receptor partial agonist antipsychotic approved by the EMA and the FDA. To address the uncertainty regarding the effectiveness of hormonal contraceptives during CAR co-administration and whether a second barrier method is necessary, a drug–drug interaction study with an oral contraceptive was conducted post-approval. …”
    Get full text
    Article
  20. 120

    Delusions of Glass Under Skin: An Unusual Case of Somatic-Type Delusional Disorder Treated with Olanzapine by Nicholas Comardelle, Amber Edinoff, Juliana Fort

    Published 2022-05-01
    “…Furthermore, this case exemplified the utility of second-generation antipsychotics in the treatment of somatic-type DD.…”
    Get full text
    Article